Rohto Pharmaceutical Co.,Ltd.

TSE:4527 株式レポート

時価総額:JP¥626.1b

Rohto PharmaceuticalLtd バランスシートの健全性

財務の健全性 基準チェック /56

Rohto PharmaceuticalLtdの総株主資本は¥264.3B 、総負債は¥44.5Bで、負債比率は16.8%となります。総資産と総負債はそれぞれ¥408.3Bと¥143.9Bです。 Rohto PharmaceuticalLtdの EBIT は¥36.8Bで、利息カバレッジ比率-19.7です。現金および短期投資は¥64.5Bです。

主要情報

16.8%

負債資本比率

JP¥44.54b

負債

インタレスト・カバレッジ・レシオ-19.7x
現金JP¥64.50b
エクイティJP¥264.34b
負債合計JP¥143.92b
総資産JP¥408.26b

財務の健全性に関する最新情報

Recent updates

Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 15
Rohto Pharmaceutical Co.,Ltd. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07
Rohto Pharmaceutical Co.,Ltd. (TSE:4527) Shares Could Be 25% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well

Oct 20
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price

Oct 06
Shareholders Should Be Pleased With Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Price

Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down

Sep 22
Returns At Rohto PharmaceuticalLtd (TSE:4527) Appear To Be Weighed Down

Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors

Aug 25
Here's Why Rohto PharmaceuticalLtd (TSE:4527) Has Caught The Eye Of Investors

Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next

Aug 11
Rohto Pharmaceutical Co.,Ltd. Just Missed EPS By 6.8%: Here's What Analysts Think Will Happen Next

Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?

Jul 11
Does Rohto PharmaceuticalLtd (TSE:4527) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Jun 23
Calculating The Fair Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares

Jun 10
Unpleasant Surprises Could Be In Store For Rohto Pharmaceutical Co.,Ltd.'s (TSE:4527) Shares

Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

May 14
Rohto PharmaceuticalLtd (TSE:4527) Has More To Do To Multiply In Value Going Forward

These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Apr 03
These 4 Measures Indicate That Rohto PharmaceuticalLtd (TSE:4527) Is Using Debt Safely

Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Mar 21
Here's Why We Think Rohto PharmaceuticalLtd (TSE:4527) Is Well Worth Watching

Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Mar 07
Rohto PharmaceuticalLtd (TSE:4527) Is Paying Out A Larger Dividend Than Last Year

Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

Feb 26
Estimating The Intrinsic Value Of Rohto Pharmaceutical Co.,Ltd. (TSE:4527)

財務状況分析

短期負債: 4527の 短期資産 ( ¥204.9B ) が 短期負債 ( ¥111.1B ) を超えています。

長期負債: 4527の短期資産 ( ¥204.9B ) が 長期負債 ( ¥32.8B ) を上回っています。


デット・ツー・エクイティの歴史と分析

負債レベル: 4527総負債よりも多くの現金を保有しています。

負債の削減: 4527の負債対資本比率は、過去 5 年間で2.3%から16.8%に増加しました。

債務返済能力: 4527の負債は 営業キャッシュフロー によって 十分にカバー されています ( 88.6% )。

インタレストカバレッジ: 4527支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。


貸借対照表


健全な企業の発掘